It’s that time of year again when we find out who has been given the prestigious Queen’s Awards for Enterprise for outstanding achievements in four main categories. This year has seen a record number of those granted for international trade, here, we highlight a few of the winners from this category…
Queen's Awards 2018
Optimising drug development
Specialist drug development consultancy, Artemida Pharma, has been announced as one of the winners within the international trade category for this year’s awards.
“To celebrate our four-year milestone with an award as prestigious as the Queen's Award for Enterprise is a real honour and a testament to how far Artemida has come in such a short period of time driven by the extensive experience of our consultants,” reflected founder and managing partner, Dr Sarah Arbe-Barnes.
Dr Robert Miller, chief medical officer and managing partner, added: “This award will further encourage us to extend our high standard of expertise in the challenging arena of drug development to our international clients.”
Overseas growth
GIS has been recognised with a Queen’s Award for Enterprise in international trade in recognition of its growth in overseas markets for the second time.
Nick Geddes, CEO of GIS, commented: “We are very honoured to have won a second Queen’s Award — it’s a great tribute to the work done by our skilled and dedicated staff. GIS continues to grow and flourish — and we are very proud of our track record in exporting our technology across the world.”
The company, which exports high performance RIP software, electronics, software drivers and ink delivery system components for industrial inkjet printheads, has seen its overseas earnings more than double in the period 2015–2017 and now exports to more than 20 countries worldwide.
Controlling temperature
Peli BioThermal, temperature-controlled packaging and service solutions provider to the global life sciences industry, has won its second successive Queen’s Award for Enterprise.
This year, the company has won in the category of international trade (last year it was a winner in the field of innovation). The judging panel highlighted the company’s ‘outstanding short term growth in overseas sales over the last three years.
“We are proud to receive this auspicious award again, this time for international trade,” emphasized Peli BioThermal president David Williams. “It is an absolute honour to receive Royal recognition for our outstanding performance exporting our pioneering products worldwide.”
Increasing exports
Independent family-owned business that specialises in the design and manufacture of process machinery for the pharmaceutical industry, Hanningfield, has received a Queen’s Award for Enterprise for international trade.
The company has achieved growth in overseas sales, with exports representing a significant and increasing proportion of company revenue. Additionally, it has seen a rise in the number of employees at the UK factory, which has been necessary to meet the rise in demand.
“I am extremely proud of the team at Hanningfield. Hard work and supreme diligence has enabled the company to flourish on the international arena of commerce,” said Colin Ellis, founder and managing director at Hanningfield. “The industry we are dedicated to supporting has extremely high standards of compliance and quality. Without the dedication and integrity of our workforce to produce excellence we would not be in a position to receive such a high accolade as the Queen’s Awards.”
Thermal protection solutions
TP3 Global, innovator and provider of thermal protection for temperature sensitive cargo, has been recognised with the Queen’s Award for Enterprise in international trade for its SilverSkin brand.
SilverSkin has become a globally-recognised brand and is used by many pharmaceutical companies worldwide to help maintain product integrity in transit.
“We are extremely proud to achieve the prestigious Queen’s Award for Enterprise for international trade,” commented Clive Wheeldon, president of TP3 Global. “Our commitment to providing market-leading products, innovation and high-quality customer service has resulted in working with the industry’s leading pharmaceutical companies.
Glass precision
Glass industry precision engineering business, Lattimer, has secured an award in the category of international trade.
Exporting to more than 56 countries worldwide with international orders accounting for 96% of total sales, the company has been recognised for its international sales growth over the past three years.
“It is a huge privilege and honour to receive the Queen’s Award for Enterprise,” stated Lattimer Holdings CEO Stephen Waterhouse. “This award is the result of many decades of hard-work and determination. Lattimer has had to evolve and remain resilient since setting up in 1937. It took many years to build a reputation as a solid British manufacturer before a major breakthrough in the 1970s when we helped a local glass container company solve a problem in their production process. This innovation was so successful it inspired Lattimer to develop other products for the worldwide market.”
Medical tech success
Medical technology company, Elucigene Diagnostics, has been awarded with the Queen’s Award for Enterprise for outstanding success in international trade.
The company’s products are used for the rapid detection of genetic diseases such as cystic fibrosis, and more than 80% of its annual sales come from exports. Over the past two years, the company has witnessed growth in revenues of around 30% and is currently 20% ahead for this financial year.
“We are thrilled to have won this most prestigious of awards. Taking a UK-only approach to our sales would not have delivered the strong growth we wanted to see and it is great to be flying the flag for UK life sciences in so many international markets,” said chief executive Dr Mark Street-Docherty. “We have a strong pipeline of new diagnostic products and ambitious plans to expand into new markets, particularly the US, in early 2019, and I hope this award will be well-received by our potential customers and partners in this and other territories.”